(RAYE) Rayliant Quantamental - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US00775Y7105
RAYE: Common Stocks, Depositary Receipts, Preferred Stock, Equity Securities
The Rayliant Quantamental Emerging Market Equity ETF (RAYE) is an actively managed exchange-traded fund that focuses on equity securities of emerging market companies, excluding those from China. The funds investment strategy is centered around a quantitative and fundamental approach, aiming to capitalize on market opportunities in emerging economies.
The Advisers definition of an emerging market company is based on the companys organization or principal place of business, allowing for a broad coverage of emerging market economies. The funds portfolio comprises a diverse range of equity securities, including common stocks, depositary receipts (both sponsored and unsponsored), preferred stocks, and securities of other investment companies, providing a comprehensive exposure to the emerging markets universe.
From a technical analysis perspective, the current price of RAYE is $24.57, indicating a potential bullish trend as it is above its 20-day and 50-day simple moving averages (SMA20: $23.47, SMA50: $22.68). However, it is below its 200-day simple moving average (SMA200: $23.98), suggesting a mixed signal. The Average True Range (ATR) of 0.37, representing 1.49% of the current price, indicates moderate volatility. Given the current technical setup, a potential price target could be the 52-week high of $26.18, assuming the bullish trend continues.
Considering the fundamental data, the Assets Under Management (AUM) of $65.83 million suggests a relatively small but still viable fund size, allowing for agility in portfolio management. Combining this with the technical analysis, a forecast for RAYE could be made. If the fund continues to demonstrate a bullish trend, breaking above its SMA200 and maintaining a stable ATR, it may reach or surpass its 52-week high. Conversely, a decline below the SMA50 could signal a bearish trend, potentially targeting the 52-week low of $20.28. Therefore, a potential forecast is that RAYE may continue its upward trajectory, potentially reaching $26.50 in the near term, based on its current technical and fundamental profile.
Additional Sources for RAYE ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
RAYE ETF Overview
Market Cap in USD | 70m |
Category | Diversified Emerging Mkts |
TER | 0.88% |
IPO / Inception | 2021-12-15 |
RAYE ETF Ratings
Growth Rating | 14.4 |
Fundamental | - |
Dividend Rating | 52.0 |
Rel. Strength | -7.09 |
Analysts | - |
Fair Price Momentum | 24.65 USD |
Fair Price DCF | - |
RAYE Dividends
Dividend Yield 12m | 3.35% |
Yield on Cost 5y | 3.75% |
Annual Growth 5y | 71.71% |
Payout Consistency | 66.5% |
Payout Ratio | % |
RAYE Growth Ratios
Growth Correlation 3m | 96.3% |
Growth Correlation 12m | -43.1% |
Growth Correlation 5y | 70.4% |
CAGR 5y | 4.33% |
CAGR/Max DD 5y | 0.16 |
Sharpe Ratio 12m | 0.60 |
Alpha | -4.68 |
Beta | 0.673 |
Volatility | 13.45% |
Current Volume | 2.8k |
Average Volume 20d | 3k |
As of July 01, 2025, the stock is trading at USD 26.39 with a total of 2,849 shares traded.
Over the past week, the price has changed by +4.27%, over one month by +7.39%, over three months by +17.72% and over the past year by +6.58%.
Neither. Based on ValueRay´s Analyses, Rayliant Quantamental is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 14.42 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of RAYE is around 24.65 USD . This means that RAYE is currently overvalued and has a potential downside of -6.59%.
Rayliant Quantamental has no consensus analysts rating.
According to our own proprietary Forecast Model, RAYE Rayliant Quantamental will be worth about 28.2 in July 2026. The stock is currently trading at 26.39. This means that the stock has a potential upside of +6.71%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 28.2 | 6.7% |